| Morgan Taylor Fisher, MS, CF-SLP | |
|
140 Cabarrus Ave W, Concord, NC 28025-5150 | |
| (704) 239-6321 | |
| Not Available |
| Full Name | Morgan Taylor Fisher |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 140 Cabarrus Ave W, Concord, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215551569 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Morgan Taylor Fisher, MS, CF-SLP 850 Tanglewood Dr Ne, Concord, NC 28025-2580 Ph: () - | Morgan Taylor Fisher, MS, CF-SLP 140 Cabarrus Ave W, Concord, NC 28025-5150 Ph: (704) 239-6321 |
News Archive
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
According to initial results of a multi-site landmark study, led by Dominic Raj, M.D., at the George Washington University (GW) site, cardiovascular disease morbidity is significantly reduced through intensive management of high blood pressure.
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.
UMB Healthcare Services, a division of UMB Financial Corporation (NASDAQ: UMBF), announced today that they were selected by Blue Cross and Blue Shield of Kansas City to provide Health Savings Accounts (HSA) to its customers.
› Verified 2 days ago
Cynthia Valderrey Bernett, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10636 Rippling Stream Dr Nw, Concord, NC 28027 Phone: 980-248-1734 | |
Pediatric Therapuetic Coaching Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Rolling Hills Ct, Concord, NC 28025 Phone: 704-787-0224 | |
Mrs. Natasha Suzanne Homan, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3733 Bentley Pl Sw, Concord, NC 28027 Phone: 980-248-1887 | |
Ms. Monica L Adams, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8611 Concord Mills Blvd, #445, Concord, NC 28027 Phone: 704-352-2461 | |
Ms. Jill Gwaltney Blankenberg, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5350 Vinning St, Concord, NC 28027 Phone: 704-783-2580 | |
Natalie Lynn Weisman, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 3700 Taylor Glen Ln Nw, Concord, NC 28027 Phone: 704-788-6510 | |
Speech From The Heart Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6013 Monticello Dr Nw, Concord, NC 28027 Phone: 704-701-6035 |